Lisa A Conte is CEO and President of Jaguar Health, Inc.. Currently has a direct ownership of 7,295 shares of JAGX, which is worth approximately $8,097. The most recent transaction as insider was on May 17, 2024, when has been sold 2,695 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.3K
0% 3M change
98.12% 12M change
Total Value Held $8,097

LISA A CONTE Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Exercise of conversion of derivative security
-
2,695 Added 26.98%
7,295 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
600 Added 11.54%
4,600 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
-
383,605 Added 49.74%
387,605 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
2,694 Added 40.24%
4,000 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
600 Added 31.48%
1,306 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
-
45,000 Added 45.92%
53,003 Common Stock
Sep 13 2021
BUY
Open market or private purchase
$20,000 $2.51 p/Share
7,968 Added 49.89%
8,003 Common Stock
LAC

Lisa A Conte

CEO and President
San Francisco, CA

Track Institutional and Insider Activities on JAGX

Follow Jaguar Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

News

Receive news related to Jaguar Health, Inc.

Track Activities on JAGX